Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.90
Bid: 297.20
Ask: 297.40
Change: -5.40 (-1.79%)
Spread: 0.20 (0.067%)
Open: 301.70
High: 302.90
Low: 295.20
Prev. Close: 302.30
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

10 Jul 2012 07:01

RNS Number : 2876H
Marks & Spencer Group PLC
10 July 2012
 



Issued: 10 July 2012

MARKS AND SPENCER GROUP PLC

QUARTER 1 2012/13 INTERIM MANAGEMENT STATEMENT

13 weeks to 30 June 2012

 

·; Group sales -0.7% *

·; Total UK sales -0.9%:Food +2.9%; GM -5.1%

·; Like for like UK sales -2.8%:Food +0.6%; GM -6.8%

·; Multi-channel sales +14.9%

·; International sales +0.9% *

 

* Stated on constant currency basis. International sales at actual currency were -3.5% as a result of the weakening Euro exchange rate.

 

Marc Bolland, Chief Executive said:

"Our Food business has again performed strongly. General Merchandise underperformed in a difficult trading season. We are confident we are taking the necessary steps to address this.

 

"We are pleased with the performance in Multi-channel and our key International businesses, which are continuing to make good progress."

 

Trading summary

Our Food business performed well, despite a tough market and challenging comparatives. We maintained our focus on freshness, speciality and convenience. We continued to lead the way with high quality, first to market products, launching over 700 new products, including over 200 British inspired lines. Customers once again placed their trust in us at special times of the year, celebrating the Jubilee weekend in style with M&S products. At a time when value is front of mind for our customers, we launched 'Simply M&S', a range of c. 800 lines highlighting the great value we offer on everyday basics, without compromising on quality.

 

Clothing sales continued to be impacted by the merchandising issues in our Spring/Summer collections reported in April, but we have taken steps to strengthen the team, improve our buying and merchandising, and bring stock back on target for the Autumn/Winter season, which launches in stores later this month. The clothing market continued to be highly promotional throughout the quarter, especially in womenswear, in part due to unseasonal weather conditions. This affected categories such as casual tops, which, given our high market share, are key performance drivers at this time of year. The strongest performing categories in the last few weeks included Coats, Jackets and Hosiery, and we also saw a good performance in Indigo and Schoolwear. We offered customers better value, and more choice at the 'Good' end of the product range which traded well.

 

In Home our key departments of kitchens, bedrooms and bathrooms delivered a positive performance. Other sales continue to be impacted by our decision to withdraw from technology as well as weak demand for big ticket items.

 

We continue to make good progress with the roll-out of our new store concept, which is being delivered on plan and on budget.

 

Multi-channel performed well with sales up 14.9%, ahead of the market. We launched a number of new initiatives aimed at improving our customers' shopping experience, including the re-launch of our mobile website.

 

Our key International markets in India and China continued to trade strongly with double digit growth. However, sales were impacted by currency translation of Euro denominated countries as well as continued macro-economic weakness in the Republic of Ireland and Greece and on-going restructuring of our Central European business.

 

Guidance

Existing guidance for the financial year 2012/13 remains unchanged.

 

Outlook

While we expect the short term trading outlook to continue to be challenging, we are making strong progress against our goal of becoming an international, multi-channel retailer.

Marks and Spencer Group plc will report its half year results for the 26 weeks ending 29 September 2012, on 6 November 2012.

 

Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences and prospects are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect Marks & Spencer's current expectations concerning future events and actual results may differ materially from current expectations or historical results. Any such forward-looking statements are subject to various risks and uncertainties, including failure by Marks & Spencer to predict accurately customer preferences; decline in the demand for products offered by Marks & Spencer; competitive influences; changes in levels of store traffic or consumer spending habits; effectiveness of Marks & Spencer's brand awareness and marketing programmes; general economic conditions or a downturn in the retail or financial services industries; acts of war or terrorism worldwide; work stoppages, slowdowns or strikes; and changes in financial and equity markets.

 

- Ends -

For further information, please contact:

 

Investor Relations:

Majda Rainer +44 (0)20 8718 1563

Richard Harris +44 (0)20 8718 9688

 

Corporate Press Office: +44 (0)20 8718 1919

Out of hours calls: +44 (0)20 8718 2000

 

Investors & Analysts Conference Call:

This will be hosted by Marc Bolland at 08:00am on Tuesday 10 July 2012:

Dial in number: +44 (0)20 8515 2334

 

A recording of this call will be available until 21 July 2012:

 

Dial in number: +44 (0)20 7959 6720

Access Code: 4548548#

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFGGUMAMUPPUAU
Date   Source Headline
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.